Executive Vice President, Chief Legal Officer · BIOGEN INC. (BIIB)

Susan Alexander

A named executive officer of BIOGEN in every fiscal year CompBrief holds from FY2016 to FY2025. Every figure below is printed as the company filed it and cited to the filing it came from.

Velarion Intel: free for 3 days, no card →

Total disclosed compensation, FY2025

$8,132,517

FY2024: $6,505,829

2nd of 6 named executive officers at Biogen by FY2025 total.

6 named officers on file for BIOGEN, FY2025

See an example →

What this number hides

The filing gives the total. BIOGEN’s full Executive Compensation Report gives every award, the disclosed peer set and what the total leaves out — the pair adds the board’s.

Velarion Intel · free for 3 days · no card

See how BIOGEN’s whole pay program stands against its peers

  • BIOGEN’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on BIIB→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 28, 2026 (DEF 14A).

Free

Get Susan Alexander’s full pay file as a PDF — free

More than this page: up to 10 years of Susan’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Susan Alexander and every company like it: Velarion Intel, free for 3 days, no card →

Susan Alexander compensation by year

BIOGEN Summary Compensation Table · all 10 fiscal years held
In US dollars, as BIOGEN reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Salary$693,663$720,630$746,254$772,373$809,695$832,173$879,407$924,417$954,192$1,028,111
Bonus$0$0$0$0$0$0$0$0—$0
Stock awards$2,337,051$3,157,338$4,359,590$3,302,619$3,583,281$3,408,917$4,155,317$4,600,947$3,879,219$5,845,129
Option awards$0$0$0$0$0$0$0$0—$0
Non-equity incentive$589,514$856,305$858,744$1,033,451$606,392$813,659$1,177,397$846,611$1,516,537$1,062,219
Pension and deferred compensation$133,726$148,961$188,056$164,782$311,416$441,999$436,869$148,759—$37,718
All other$171,114$178,008$201,140$181,785$159,261$142,558$141,162$183,118$155,881$159,340
Total$3,925,068$5,061,242$6,353,784$5,455,010$5,470,045$5,639,306$6,790,152$6,703,852$6,505,829$8,132,517

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: BIOGEN INC. DEF 14A filed April 28, 2026, accession 0001193125-26-187303, and prior-year filings. Open the filing on EDGAR.

How this page was built: the BIOGEN INC. filed document, accession 0001193125-26-187303. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2026.

$3.9M
$5.1M
$6.4M
$5.5M
$5.5M
$5.6M
$6.8M
$6.7M
$6.5M
$8.1M
FY16
FY17
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
SalaryNon-equity incentiveStock awardsAll other

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
RSU14,750$2,595,853—
PSU11,065$1,947,329—
RSU3,880$682,841—
RSU2,190$385,418—
PSU2,183$384,186—
PSU1,091$192,005—

Per the Outstanding Equity Awards at Fiscal Year-End table in BIOGEN INC.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

BIOGEN’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Christopher ViehbacherPresident and Chief Executive Officer$23,646,004
Susan Alexander · this pageExecutive Vice President, Chief Legal Officer$8,132,517
Nicole MurphyHead of Pharmaceutical Operations and Technology$7,575,505
Priya SinghalHead of Development$7,571,387
Robin KramerExecutive Vice President and Chief Financial Officer$5,806,584
Michael McDonnellFormer Executive Vice President and Chief Financial Officer$270,850

Susan Alexander's compensation dossier, BIOGEN

You have read Susan Alexander's totals and holdings. The dossier adds each equity grant BIOGEN disclosed for Susan Alexander and BIOGEN's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.

See an example →

The full BIOGEN compensation record

free company brief

This page is one person within BIOGEN's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the BIOGEN proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order BIOGEN's full Executive Compensation Report with peer benchmarking.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are BIOGEN's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Order BIIB

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Susan Alexander's compensation dossier